scispace - formally typeset
F

F. Sautel

Researcher at French Institute of Health and Medical Research

Publications -  14
Citations -  1363

F. Sautel is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Dopamine receptor D3 & Dopamine receptor D2. The author has an hindex of 11, co-authored 12 publications receiving 1337 citations.

Papers
More filters
Journal ArticleDOI

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist.

TL;DR: BP 897 inhibits cocaine-seeking behaviour that depends upon the presentation of drug-associated cues, without having any intrinsic, primary rewarding effects, which indicates that compounds like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug- associated environmental stimuli.
Journal ArticleDOI

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

TL;DR: The known behavioural actions of D3 selective agonists support a role for the D3 receptor in motor inhibitions, which should be taken into account for the treatment of motor dysfunctions by dopamine agonists.
Journal Article

Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.

TL;DR: These studies establish nafadotride as a pure, extremely potent, competitive and preferential dopamine D3 receptor antagonist in vitro.
Journal ArticleDOI

Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence.

TL;DR: It is suggested that theDRD3 gene may have a role in drug dependence susceptibility in individuals with high sensation-seeking scores, consistent with the role of DRD3 in mediating responses to drugs of abuse in animals and the association of homozygosity at the Bal I polymorphism with drug abuse in schizophrenic patients.
Journal ArticleDOI

Dopamine D3 receptor gene variants and substance abuse in schizophrenia.

TL;DR: It is proposed that homozygosity for the Bal I polymorphism DRD3 gene is associated with predisposition to substance abuse and/or the pharmacosensitive characteristic of schizophrenia rather than with schizophrenia itself, an hypothesis in agreement with the positive association of this polymorphism with opiate dependence